Low expression of immune checkpoint molecules in cluster CD8_3 of CD8+ T cells in the TME may result in low risk of early disease progression and non-aggressive histological properties in ccRCC (Ballesteros et al., 2021). Here, CD8A is linked to nonpapillary renal cell carcinoma.